For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Nootropic / Cognitive

Oxytocin

Also known as: Pitocin (IV obstetric)

Oxytocin is a nine-amino acid peptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with a disulfide bridge between Cys1 and Cys6) produced in the hypothalamic paraventricular and supraoptic nuclei. The synthetic form (Pitocin) is FDA-approved as IV/IM injection for labor induction/augmentation and postpartum hemorrhage control. Intranasal oxytocin is NOT FDA-approved and is used off-label or in research settings for social/behavioral indications, where evidence is mixed.

Where to buy · live market data

Who's worth your money for Oxytocin

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (99) of 18 scored sellers

$5.60/mg

$55.99 · 10mg

no COAs yet
Buy code MERIT · 10% off

Best value

Lowest $/mg among scored sellers

$3.50/mg

$35.00 · 10mg

no COAs yet

Most tested

5 independent COAs on file

$6.50/mg

$64.97 · 10mg · 99.9% purity

5 COAs
Buy code MERIT · 15% off

Average price

$8.99/mg

Sellers

46

45-day trend

-2.9%

37 of 46 sellers have a current price· 12 stale hidden· 7 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch Oxytocin

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About Oxytocin

CAS

50-56-6

Molecular formula

C43H66N12O12S2

Sequence

CYIQNCPLG

Typical dose range

24 IU intranasal per administration (common research dose); 24-40 IU intranasal studied in clinical trials; IV obstetric use (Pitocin) is weight/indication-based and distinct from research protocols

Half-life

~3-5 minutes (IV, peripheral plasma)

Independent evidence

COAs for Oxytocin

52 third-party tests across 21 vendors. Each card links to the full report.

All 52 COAs for Oxytocin →
Measured purity 96.3%–100.0% across 39 COAs
Measured purity over time
Aggregated · 3rd-party listing
98.56 %
Aug 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Peptide Plugs· batch 71040L-DK

Aggregated · 3rd-party listing
99.49 %
Jul 2026
ILS Labs Strong

For

Oxytocin

by Ion Peptide· batch OT2-06172026

✓ Vendor-published
99.49 %
Jul 2026
ILS Laboratories

For

Oxytocin

by Ion Peptide· batch OT2-06172026

COA on file
Aggregated · 3rd-party listing
99.48 %
Jun 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Peptide Supply Co.· batch OX10-06032026

Aggregated · 3rd-party listing
99.76 %
May 2026
Freedom Diagnostics Moderate

For

Oxytocin

by True Peptide· batch OXYT-162-TPL

Aggregated · 3rd-party listing
99.51 %
May 2026
Horizon Analytical

For

Oxytocin

by Blank Peptides· batch B-1340958-P

Aggregated · 3rd-party listing
99.41 %
May 2026
Horizon Analytical

For

Oxytocin

by Pepsgpt· batch P-4275312-P

✓ Vendor-published
99.54 %
May 2026
ILS Laboratories

For

Oxytocin

by Ion Peptide· batch DTI0-0430 2026

COA on file
Aggregated · 3rd-party listing
97.53 %
Apr 2026
Janoshik Analytical Limited · HPLC

For

Oxytocin

by Peptidegurus· batch cmojgra8k00339grxn334qvo9

Aggregated · 3rd-party listing
99.97 %
Mar 2026
Kovera Labs

For

Oxytocin

by Ion Peptide· batch OT2-03242026

✓ Vendor-published
99.97 %
Mar 2026
Kovera Labs

For

Oxytocin

by Ion Peptide· batch OT2-03242026

COA on file
Aggregated · 3rd-party listing
99.93 %
Mar 2026
Kovera Labs · HPLC

For

Oxytocin

by Mile High Compounds· batch OXN-010-MH-01

Aggregated · 3rd-party listing
98.70 %
Mar 2026
Janoshik Analytical Limited · HPLC

For

Oxytocin

by Profound Aminos· batch cmojb87g401hikirxz7zxvzut

Aggregated · 3rd-party listing
99.18 %
Mar 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Peptide Tech· batch O5O-9845

Aggregated · 3rd-party listing
99.79 %
Feb 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Welli Labs· batch WLOXT-10-10001

Aggregated · 3rd-party listing
99.46 %
Feb 2026
Janoshik Analytical Limited

For

Oxytocin

by EZ Peptides· batch EZP-OXY1002092026-01

✓ Vendor-published
99.46 %
Feb 2026
Janoshik Analytical Limited

For

Oxytocin

by EZ Peptides· batch EZP-OXY1002092026-01

COA on file
Aggregated · 3rd-party listing
99.67 %
Feb 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Modern Research Peptides· batch HKBCOT226

✓ Vendor-published
99.01 %
Jan 2026
Janoshik Analytical Limited

For

Oxytocin

by Ruo Bio

COA on file
Aggregated · 3rd-party listing
99.05 %
Jan 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Modern Research Peptides· batch LCN261OT2

Aggregated · 3rd-party listing
97.31 %
Jan 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Southern Aminos· batch OX101225A

✓ Vendor-published
99.28 %
Jan 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Ion Peptide· batch OT2-123125

COA on file
Aggregated · 3rd-party listing
99.28 %
Jan 2026
Freedom Diagnostics Moderate

For

Oxytocin

by Ion Peptide· batch OT2-123125

✓ Vendor-published
99.48 %
Dec 2025
Freedom Diagnostics Moderate

For

Oxytocin

by Ion Peptide· batch OT2-121925

COA on file
Research depth

20 citations indexed for Oxytocin

All research on Oxytocin →

Study · 2026

Relation between serum oxytocin levels and impulsivity in patients under treatment for alcohol use disorder

Objective Due to shared oxytocin pathways in impulsivity and alcohol use disorder (AUD), impulsivity is thought to increase susceptibility to AUD through the oxytocin system. This study investigated this relationship in patients under treatment for alcohol use disorder.

review · 2026

Oxytocin discontinuation after the active phase of induced labour: an overview of systematic reviews

Background To synthesize the available evidence on the effects of discontinuing oxytocin after the onset of the active phase of induced labour. Methods An overview of seven systematic reviews (SRs) and meta-analyses was conducted.

Study · 2026

Oxytocin Use During Labour: An Analysis of Canadian Medico-legal Obstetrical Case Files

Objective We used Canadian medico-legal case data to examine patterns of oxytocin use in labour induction and augmentation and explore factors associated with adverse maternal-neonatal outcomes.

animal · 2026

Gene-environment interaction between perinatal oxytocin exposure and Pten mutation shapes epigenetic reprogramming of oxytocin signaling and behavior in mice

Synthetic oxytocin (Pitocin) is the most commonly used pharmacologic agent for induction and augmentation of labor. Beyond its uterotonic effects, oxytocin plays a critical role in neurodevelopment and social behavior.

cohort · 2026

Comparative genomic analysis of oxytocin and oxytocin receptor genes in the family Equidae

Background The oxytocin (OXT) - oxytocin receptor (OXTR) system regulates diverse biological processes including social behavior, stress responses, and processes related to domestication. While OXT is highly conserved, OXTR shows greater variability, which may contribute to species-specific adaptations.

review · 2026

Anterior cingulate cortex, anterior insular cortex and altruistic behaviors; a hypothetical role for oxytocin

This paper reviews evidence that neurons in the anterior cingulate cortex (ACC) and anterior insular cortex (AI) are involved in the production of altruistic behaviors.